{"prompt": "['Alliance A221701', '37.', 'Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for', 'determining responsiveness and minimally important differences for patient-reported outcomes. J Clin', 'Epidemiol, 61(2), 102-109. doi:10.1016/j.jclinepi.2007.03.012', '38.', 'Clinical significance of patient-reported questionnaire data: another step toward', 'consensus. Sloan, Jeff A. Cella, David, Hays, Ron D. et al. Journal of Clinical Epidemiology, Volume 58', ', Issue 12, 1217 - 1219, 2005)', '39.', 'Freidlin B, McShane LM, Polley MY, et al: Randomized phase II trial designs with', 'biomarkers. J Clin Oncol 30:3304-9, 2012', '40.', 'Xiao L, Lavori PW, Wilson SR, et al: Comparison of dynamic block randomization and', 'minimization in randomized trials: a simulation study. Clin Trials 8:59-69, 2011', '41.', 'Pamela J Atherton, Kelli N Burger, Levi D Pederson, Suneetha Kaggal, Jeff A Sloan.', 'Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance', 'N0992). Clinical Trials, Vol 13, Issue 6, pp. 612 - 620. June 30, 2016', 'ttps://doi.org/10.1177/1740774516655101)', '42.', 'Jefrey L. Huntington, BS, Amylou Dueck, PhD. Handling Missing Data. Current', 'Problems in Cancer, November-December, 2005Volume 29, Issue 6, Pages 317-325', '43.', 'Jeff A. Sloan PhD, Amylou C. Dueck PhD, Pennifer A. Erickson PhD, Harry Guess MD,', 'PhD, Dennis A. Revicki PhD, Nancy C. Santanello MD, MS and the Mayo/FDA Patient-Reported', 'Outcomes Consensus Meeting Group. Analysis and Interpretation of Results Based on Patient-Reported', 'Outcomes. Value in Health Volume 10, Issue Supplement s2, pages S106-S115, November/December', '2007 DOI: 10.1111/j.1524-4733.2007.00273', '44.', 'Cros J, Moati E, Raffenne J, Hentic O, Svrcek M, de Mestier L, Sbidian E, Guedj N,', 'Bedossa P, Paradis V, Sauvanet A, Panis Y, Ruszniewski P, Couvelard A, Hammel P. Gly388Arg FGFR4', 'Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine', 'Tumors. Neuroendocrinology. 2016;103(5):495-9. doi: 10. .1159/000440724. Epub 2015 Sep 4', '45. Serra S, Zheng L, Hassan M, Phan AT, Woodhouse LJ, Yao JC, Ezzat S, Asa SL.', 'The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression', 'and response to m TOR inhibition therapy. Cancer Res. 2012 Nov 15;72(22):5683-91. doi: 10.1158/0008-', '5472.CAN-12-2102. Epub 2012 Sep 17. PubMed PMID: 22986737', '46.', 'Pouch\u00e9 L, Stojanova J, Marquet P, Picard N. New challenges and promises in', 'solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the', 'pharmacodynamics of immunosuppressive drugs. Pharmacogenomics.; 17(3):277-96. doi:', '10.2217/pgs.15.169. Epub 2016 Jan 22. Review. PubMed PMID: 26799749.', '47.', 'Pascual T, ApellA\u00a1niz-Ruiz M, Pernaut C, Cueto-Felgueroso C, Villalba P, Alvarez', 'Manso L, Inglada-PA\u00a9re L, Robledo M, RodrAguez-Antona C, Ciruelos E. Polymorphisms associated', 'with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer. PLoS One. 2017 Jul', '20;12(7):e0180192. doi:10.1371/journal.pone.0180192. eCollection 2017. PubMed PMID: 28727815;', 'PubMed Central PMCID: PMC5519037.', '48.', 'Jiang J, Fridley BL, Feng Q, Abo RP, Brisbin A, Batzler A, Jenkins G, Long PA, Wang', 'L. Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a', 'lymphoblastoid cell line system. Front Genet. 2013 Aug 30;4:166. doi: 10.3389/fgene.2013.00166.', 'eCollection 2013. PubMed PMID: 24009623; PubMed Central PMCID: PMC3757297.', '49.', 'Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ.', 'Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 2001', 'Oct 5;294(5540):173-7 Epub 2001 Aug 30. PubMed PMID: 11533444.', '50. Fujii Y, Yada M, Nishiyama M, Kamura T, Takahashi H, Tsunematsu R, Susaki E,', 'Nakagawa T, Matsumoto A, Nakayama KI. Fbxw7 contributes to tumor suppression by targeting multiple', 'proteins for ubiquitin-dependent degradation. Cancer Sci. 2006 Aug;97(8):729-36. PubMed PMID:', '16863506', '59', 'NCI version date 8/14/2020', 'Update #03']['Alliance A221701', '51.', 'Zhou Z, He C, Wang J. Regulation mechanism of Fbxw7-related signalingPathways', '(Review). Oncol Rep. 2015 Nov;34(5):2215-24. doi: 10.3892/or.2015.4227 Epub 2015 Aug 26. Review.', 'PubMed PMID: 26324296', '52.', 'Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads', 'of cell division, growth and differentiation. Nat Rev Cancer. 2008 Feb;8(2) :83-93. Review. PubMed', 'PMID: 18094723.', '53.', 'Siu, K. T., Rosner, M. R., & Minella, A. C. (2012). An integrated view of cyclin E', 'function and regulation. Cell Cycle, 11(1), 57-64.http://doi.org/10.4161/cc.11.1.18775.57-64.PMC.', 'Web. 23 Oct. 2017.', '54.', 'Davis RJ, Welcker M, Clurman BE. Tumor suppression by the Fbw7 ubiquitin ligase:', 'mechanisms and opportunities. Cancer Cell. 2014 Oct 3;26(4):455-64. doi: 10.1016/j.ccell.2014.09.013.', 'Review. PubMed PMID: 25314076; PubMed Central PMCID:PMC4227608.', '55.', 'Glorioso N, Herrera VL, Didishvili T, Argiolas G, Troffa C, Bulla P, Bulla E, Ruiz-', 'Opazo N. DEspR T/CATAAAA-box promoter variant decreases DEspR transcription and is associated', 'with increased BP in Sardinian males. Physiol Genomics. 2011 Nov 7;43(21): 1219-25. doi:', '10.1152/physiolgenomics.00012.201 Epub 2011 Aug 23. PubMed PMID: 21862670; PubMed Central', 'PMCID: PMC3217322', '56.', 'Wight JE, Nguyen VH, Medina MT, Patterson C, Dur\u00c4\u00b3n RM, Molina Y, Lin YC,Mart\u00c3-', 'nez-Ju\u00c1jrez IE, Ochoa A, Jara-Prado A, Tanaka M, Bai D, Aftab S, Bailey JN, Delgado-Escueta AV.', 'Chromosome loci vary by juvenile myoclonic epilepsy subsyndromes: linkage and haplotype analysis', 'applied to epilepsy and EEG 3.5-6.0\u00c2 Hz polyspike waves. Mol Genet Genomic Med. 2016 Jan', '23;4(2):197-210. oi:10.1002/mgg3.195. eCollection 2016 Mar. PubMed PMID: 27066514; PubMed', 'Central PMCID: PMC4799870.', '57.', 'J.A. Sloan, D. Vargas-Chanes, C.C. Kamath, D.J. Sargent, P.J. Novotny, P. Atherton, C.', 'Allmer, .L.Fridley, M.H. Frost, C.L. LoprinziDetecting worms, ducks and elephants: a simple approach', 'for defining clinically relevant effects in quality-of-life measures J Cancer Integr Med, 1 (2003), pp. 41-', '47', '58.', 'Lim SM, Park HS, Kim S, Kim S, Ali SM, Greenbowe JR, Yang IS, Kwon NJ, Lee JL,', 'Ryu MH, Ahn JH, Lee J, Lee MG, Kim HS, Kim H, Kim HR, Moon YW, Chung HC, Kim JH, Kang YK,', 'Cho BC. Next-generation sequencing reveals somatic mutations that confer exceptional response to', 'everolimus. Oncotarget. 2016 Mar 1;7(9):10547-56. doi: 10.18632/oncotarget. 7234. PMID:26859683', '59.', 'Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, et al.', 'Therapeutic Drug Monitoring of Everolimus: A Consensus Report. Therapeutic drug monitoring.', '2016;38(2):143-69. Epub 2016/03/18. omid:26982492', '60.', 'Tszyrsznic, W., Borowiec, A., Pawlowska, E., Jazwiec, R., Zochowska, D.,', 'Bartlomiejczyk, I., Dadlez, M. (2013). Two rapid ultra-performance liquid chromatography/tandem mass', 'spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug', 'monitoring of immunosuppressants compared to immunoassay. Journal of Chromatography B, 928, 9-15.', 'doi:https://doi.org/10.1016/j.jchromb.2013.03.014', '61.', 'Foote RL, Loprinzi CL, Frank AR, et al: Randomized trial of a chlorhexidine mouthwash', 'for alleviation of radiation-induced mucositis. J Clin Oncol 12:2630-3, 1994', '62.', 'Leenstra JL, Miller RC, Qin R, et al: Doxepin rinse versus placebo in the treatment of', 'acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy:', 'a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). J Clin Oncol 32:1571-7, 2014', '63.', 'Loprinzi CL, Cianflone SG, Dose AM, et al: A controlled evaluation of an allopurinol', 'mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 65:1879-82, 1990', '64.', 'Loprinzi CL, Ghosh C, Camoriano J, et al: Phase III controlled evaluation of sucralfate to', 'alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol 15:1235-8, 1997', '65.', 'Mahood DJ, Dose AM, Loprinzi CL, et al: Inhibition of fluorouracil-induced stomatitis', 'by oral cryotherapy. J Clin Oncol 9:449-52, 1991', '60', 'NCI version date 8/14/2020', 'Update #03']\n\n###\n\n", "completion": "END"}